| __timestamp | Johnson & Johnson | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 9216000000 |
| Thursday, January 1, 2015 | 21536000000 | 8296000000 |
| Friday, January 1, 2016 | 21685000000 | 10044000000 |
| Sunday, January 1, 2017 | 25354000000 | 11560000000 |
| Monday, January 1, 2018 | 27091000000 | 10558000000 |
| Tuesday, January 1, 2019 | 27556000000 | 9351000000 |
| Wednesday, January 1, 2020 | 28427000000 | 8933000000 |
| Friday, January 1, 2021 | 23402000000 | 8284000000 |
| Saturday, January 1, 2022 | 24596000000 | 7952000000 |
| Sunday, January 1, 2023 | 26553000000 | 8200000000 |
| Monday, January 1, 2024 | 27471000000 | 8480000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, Johnson & Johnson and Teva Pharmaceutical Industries Limited stand as titans, each with a unique financial trajectory. From 2014 to 2023, Johnson & Johnson consistently outpaced Teva in cost of revenue, reflecting its expansive operations and market reach. Notably, Johnson & Johnson's cost of revenue peaked in 2020, marking a 25% increase from 2014, while Teva's highest was in 2017, with a 26% rise from its 2014 figures. However, Teva's cost of revenue saw a decline of approximately 13% by 2023, indicating strategic shifts or market challenges. This comparison not only highlights the financial strategies of these pharmaceutical giants but also underscores the dynamic nature of the industry. As the world continues to demand innovative healthcare solutions, understanding these financial trends offers valuable insights into the operational efficiencies and market strategies of leading companies.
Cost of Revenue: Key Insights for Johnson & Johnson and Vertex Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Johnson & Johnson and BeiGene, Ltd.
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Johnson & Johnson vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Amgen Inc. and Teva Pharmaceutical Industries Limited's Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Mesoblast Limited